Jonathan J Lyons Selected Research

Mast Cell Activation Disorders (Mast-Cell Disease)

1/2022	Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis.
1/2022	Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
1/2021	Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
10/2020	Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.
11/2019	Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan J Lyons Research Topics

Disease

15	Hereditary alpha-tryptasemia syndrome 04/2022 - 01/2018
10	Anaphylaxis (Anaphylactic Shock) 01/2022 - 05/2013
6	Mastocytosis 01/2022 - 01/2019
5	Hypersensitivity (Allergy) 01/2022 - 05/2013
5	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2022 - 11/2019
5	Immediate Hypersensitivity 01/2022 - 01/2016
4	Neoplasms (Cancer) 01/2022 - 01/2019
3	Inflammation (Inflammations) 10/2021 - 01/2016
3	Mast Cell Activation Syndrome 01/2021 - 01/2019
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2015
2	Systemic Mastocytosis 01/2022 - 01/2021
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 08/2017
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2021
2	Autonomic Nervous System Diseases (Dysautonomia) 10/2019 - 12/2016
2	Joint Instability (Joint Laxity) 01/2017 - 12/2016
1	Chronic Renal Insufficiency 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Eosinophilic Esophagitis 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Cutaneous Mastocytosis 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Dermatitis 01/2021
1	Chronic Inducible Urticaria 10/2019
1	Gaucher Disease (Gaucher's Disease) 03/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2017
1	Infections 08/2017
1	Measles 01/2017
1	Optic Atrophy 01/2017
1	Rubella (German Measles) 01/2017
1	Cone Dystrophy 01/2017
1	Flushing 12/2016
1	Chronic Pain 12/2016
1	Pruritus (Itching) 12/2016
1	Wiskott-Aldrich Syndrome 10/2016
1	Food Hypersensitivity (Food Allergy) 01/2016
1	Job Syndrome (Hyper-IgE Syndrome) 01/2016
1	Eosinophilia 02/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2015

Drug/Important Bio-Agent (IBA)

26	Tryptases (Tryptase)IBA 04/2022 - 12/2016
7	Immunoglobulin E (IgE)IBA 01/2022 - 02/2015
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
2	Biological ProductsIBA 01/2022 - 01/2021
2	VenomsIBA 01/2021 - 10/2020
2	Arthropod VenomsIBA 01/2021 - 10/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2016 - 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2022
1	NucleotidesIBA 01/2021
1	MitogensIBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	CytokinesIBA 09/2017
1	AlbuminsIBA 01/2017
1	Retinaldehyde (Retinal)IBA 01/2017
1	AllergensIBA 10/2016
1	Histamine Receptors (Histamine Receptor)IBA 01/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Filgrastim (Neupogen)FDA Link 05/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2018
1	Hematopoietic Stem Cell Transplantation 01/2016